Align Technology (ALGN) announced that it has received CE Mark in Europe under the Medical Device Regulation for Align’s Invisalign Palatal Expander System. The Invisalign Palatal Expander System has also completed registration with MHRA for the United Kingdom and overseas territories. Both approvals are for broad patient applicability, including growing children, teens, and adults. These approvals mark a significant milestone in Align’s efforts to enhance clinical outcomes and efficiency in orthodontics. The Invisalign Palatal Expander System is a modern and innovative direct 3D printed device based on proprietary and patented technology. Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla with primary, mixed, or permanent dentition during treatment of patients.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology announces $275M open market repurchase
- Align Tech Announces $275 Million Stock Buyback Plan
- Early notable gainers among liquid option names on October 24th
- Align Technology price target lowered to $280 from $310 at Morgan Stanley
- Align Technology price target lowered to $275 from $285 at Stifel